ArticleJournal of mid-life health
Molecular Characterization of Human Papilloma Virus in Carcinoma Cervix along with Screening of Risk Factors and their Regional Comparison.
Article in Journal of mid-life health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Background: The threat of cervical carcinoma is still a major public health challenge in low- and middle-income countries, including India. In this context, disparate findings about HPV genotypes are reported from different regions of India. Interestingly, although HPV-16 and HPV-18 have demonstrated global supremacy as risk factors for cervical cancer, recent observations from India indicate a rising trend of high-risk non-18 genotypes. Aim and objectives: To assess the prevalence, distribution of genotypes, and molecular profile of the human papillomavirus in women presenting with suspected cervical pathology in the Agra region of North India. In addition, the cytology-VIA correlation and epidemiological risk factors in the region were assessed. Material and Methods: In this hospital-based cross-sectional study, the data were collected over a period of 18 months from April 2023 to January 2025. A total of 500 symptomatic women between the age group of 25 and 65 years were included from a tertiary care hospital in Agra. Cervical samples were obtained for the Pap smear, VIA, and HPV DNA. Genotyping for various types of HPV was done by real-time PCR for 28 types of HPV. Sociodemographic, reproductive, and behavioral factors of the subjects were taken into consideration. Results: The DNA of the human papillomavirus was detected in 13% of the 500 patients. There was no association between sociodemographic and behavioral factors. Abnormal cytology was found to be highly significantly associated with the presence of the human papillomavirus. Abnormal cytology was 74.7% associated with the presence of human papillomavirus ( Conclusion: This study underlines marked regional diversity in HPV genotypes at high risk other than HPV-16/18 and confirms a strong concordance between infection with high-risk human papillomavirus and cytological abnormalities. These findings raise the demand for genotype-informed surveillance of human papillomavirus infection, expanded vaccine coverage, and integrated screening to advance the effort at cervical cancer prevention in north India.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.